Car T-cell therapy shows early promise in treating gastric cancers

Chinese researchers say interim trial results suggest approach could be important for those with advanced tumours

An experimental cancer therapy that infuses designer immune cells into patients has shown early promise in a clinical trial by shrinking tumours in the digestive system.

Interim results from the first phase of the clinical trial found that the tumours in nearly half - 48.6% - of the 37 patients treated so far reduced in size after the therapy.